others

アクセルベックス

addressTokyo/Shibuya-ku/12-8, Shibuya 1-chome
phone-
last updated：
アクセルベックスlogo

アクセルベックス List of Products and Services

1～3 item / All 3 items

Displayed results

GMP-compliant α-GalCer (KRN7000)

It can be used in human trials for NKT cell activation.

Our α-GalCer (KRN7000, α-galactosylceramide) is a GMP-compliant product, ensuring high quality and safety. For more details, please refer to the catalog.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Clinic for Cancer Patients] Cancer Immunotherapy Shin Beck

It is a cancer cell immunotherapy that processes unnecessary cancer cells and immune cells, which become unnecessary with ascites treatment CART (ascites filtration, concentration, and reinfusion method), and returns them to the patient's body.

"Shin Beck" is a cancer immunotherapy that processes the patient's own cells collected through CART (ascites treatment) and then administers them back to the patient to activate the immune cells in the body. It is possible to administer the treatment to the patient within a short period (about one week) after receiving the CART waste bag. The activated immune cells (such as NK and killer T cells) will kill the tumor cells. [Features] - Activates the immune cells in the body - Immune cells (NK and killer T cells) kill tumor cells - Can be administered to the patient within a short period (about one week) *For more details, please refer to the PDF document or feel free to contact us.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Information] KRN7000 (GMP) Project

Publication on the prospects of preventive and therapeutic vaccines, including the synthesis of α-GalCer compound (KRN7000)!

This document introduces the prospects of a preventive and therapeutic vaccine using KRN7000 (a-galactosylceramide: a-GalCer). It includes topics such as "The history of the discovery of the natural compound a-galactosylceramide," "Synthesis of the a-GalCer compound (KRN7000)," and "Mechanism of action of a-GalCer." We encourage you to read it. 【Contents】 ■ The history of the discovery of the natural compound a-galactosylceramide (α-GalCer) ■ Synthesis of the a-GalCer compound (KRN7000) ■ Mechanism of action of a-GalCer ■ Immunostimulatory effects of a-GalCer and its application in cancer treatment ■ Immunoregulatory effects of a-GalCer and its application in the treatment of allergies, autoimmune diseases, and suppression of transplant rejection *For more details, please refer to the PDF document or feel free to contact us.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration